Company / Depreciation & Amortization
ARS Pharmaceuticals, Inc. Depreciation & Amortization History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.4M
FY2025
5-year range
$79.0K / $1.4M
FY2021-FY2025
Trend
+1630.4%
vs FY2024
Sector context
#115 of 168
Health Care
What the data says
Depreciation & Amortization changed +1630% YoY in FY2025, a notable deviation from the 4-year average annual change of +386%.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of +16.5%.
Increased from $100,000 to $1M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +16.5%
- 10-Year CAGR
- -
Sector benchmark
#54 of 168 in Health CareTop 32% of 168This company $1.4M Sector average $212.9M
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.5%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 1630.4% year-over-year.
- Ranks #115 out of 168 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4M | +1630.4% |
| FY2024 | $79.0K | -21.0% |
| FY2023 | $100.0K | - |
| FY2022 | - | - |
| FY2021 | $783.0K | +22.9% |
| FY2020 | $637.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026